Shanghai Allist Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 16.47%

Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) is 16.47% for the year ending December 31, 2023, a 315.38% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 3.96%, a 523.39% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 0.64%, a 105.92% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was -10.75%, a 67.32% change year over year.
  • Shanghai Allist Pharmaceuticals Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -32.89%, a 74.17% change year over year.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
SV Wall Street
Shanghai Stock Exchange: 688578.SS

Shanghai Allist Pharmaceuticals Co., Ltd.

CEO Mr. Jinhao Du
IPO Date Dec. 2, 2020
Location China
Headquarters No. 268 Lingxiaohua Road
Employees 1,044
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials
Description

Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China.

StockViz Staff

February 2, 2025

Any question? Send us an email